← The Wire
OCGNNasdaq
Ocugen, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1372299
Ocugen develops gene therapies to treat inherited retinal diseases and blindness
red 8-K · 90d🔥 High media attention
$410M
Market cap
$1.67
Last close
+11.3%
1D
+29.5%
5D
14.2M
Volume
Price · last 39 sessions-9.7%
May 4L $1.18 · H $1.85Jun 29
432
Total filings
Jun 11, 2026
Last filing
12/31
Fiscal year end
8-KShareholder Vote · Company UpdateJun 11, 20268-KExecutive ChangeJun 3, 20268-KExecutive Change · Company UpdateMay 14, 20268-KNew Debt / Obligation · Equity IssuanceMay 14, 202610-Q10-QMay 8, 20268-KMaterial Agreement · Agreement TerminatedMay 7, 20268-KResults of Operations · Company UpdateMay 5, 20268-KResults of Operations · Reg FD DisclosureMay 4, 2026DEFA14ADEFA14AApr 28, 2026DEF 14ADEF 14AApr 28, 20268-KReg FD DisclosureMar 27, 20268-KReg FD DisclosureMar 24, 20268-KCompany UpdateMar 20, 202610-K10-KMar 4, 20268-KCompany UpdateMar 4, 20268-KResults of OperationsMar 4, 20268-KExecutive ChangeFeb 9, 20268-KReg FD Disclosure · Company UpdateJan 23, 20268-KMaterial Agreement · Company UpdateJan 21, 2026424B5424B5Jan 21, 20268-KCompany UpdateJan 15, 20268-KExecutive ChangeDec 18, 202510-Q10-QNov 5, 20258-KResults of OperationsNov 5, 20258-KAgreement TerminatedSep 18, 20258-KMaterial AgreementSep 16, 20258-KMaterial AgreementSep 5, 20258-KMaterial Agreement · Reg FD DisclosureAug 11, 2025424B5424B5Aug 11, 202510-Q10-QAug 4, 20258-KResults of OperationsAug 1, 20258-KCompany UpdateJul 30, 20258-KCompany UpdateJul 29, 20258-KDelisting NoticeJul 1, 20258-KMaterial Agreement · Reg FD DisclosureJun 23, 20258-KCompany UpdateJun 17, 20258-KShareholder Vote · Company UpdateJun 5, 20258-KResults of OperationsMay 9, 202510-Q10-QMay 9, 20258-KReg FD DisclosureMay 1, 2025DEFA14ADEFA14AApr 25, 2025DEF 14ADEF 14AApr 25, 20258-KExecutive ChangeApr 25, 20258-KCompany UpdateApr 4, 202510-K10-KMar 5, 20258-KResults of OperationsMar 5, 20258-KCompany UpdateMar 3, 20258-KCompany UpdateFeb 12, 20258-K/AMaterial Agreement · New Debt / ObligationFeb 7, 20258-KCompany UpdateJan 29, 20258-KDelisting NoticeJan 3, 20258-KCompany UpdateDec 3, 20248-KExecutive ChangeNov 15, 202410-Q10-QNov 14, 20248-KReg FD DisclosureNov 12, 20248-KMaterial Agreement · New Debt / ObligationNov 8, 2024SC 13GSC 13GNov 8, 20248-KResults of OperationsNov 8, 2024SC 13GSC 13GOct 22, 20248-KCompany UpdateAug 13, 20248-KResults of OperationsAug 8, 202410-Q10-QAug 8, 20248-KCompany UpdateAug 5, 2024424B5424B5Aug 1, 20248-KMaterial Agreement · Company UpdateAug 1, 2024424B5424B5Jul 31, 20248-KAuditor ChangeJul 8, 20248-KShareholder VoteJun 28, 2024DEFA14ADEFA14AJun 18, 20248-KAuditor ChangeJun 6, 2024DEF 14ADEF 14AMay 28, 20248-KResults of OperationsMay 14, 202410-Q10-QMay 14, 20248-KSecurity-Holder Rights · Bylaw AmendmentMay 10, 202410-K/AFORM 10-K/AApr 29, 20248-KReg FD DisclosureApr 29, 202410-K10-KApr 16, 20248-KCompany UpdateApr 8, 20248-KResults of OperationsApr 2, 20248-KRestatement · Company UpdateApr 1, 2024
In the News
🔥 High media attentionCoverage (30d): 11 reputable articles.
MarketWatchOcugen Inc. stock rises Monday, outperforms market14h agoMarketWatchOcugen Inc. stock falls Thursday, underperforms market4d agoMarketWatchOcugen Inc. stock rises Tuesday, outperforms market6d agoMarketWatchOcugen Inc. stock rises Wednesday, outperforms market12d agoMarketWatchOcugen Inc. stock falls Tuesday, underperforms market13d agoMarketWatchOcugen Inc. stock rises Thursday, outperforms market18d ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance